Article headline
Trends

Explained: Why Is Oxford-AstraZeneca Been Suspended In Some Countries?

Oxford-AstraZeneca is found amidst controversy after its vaccine model was suspended in Denmark when some of the citizens were subjected to blood clots.

Amongst all the COVID-19 vaccines, Oxford-Astrazeneca was one of the first vaccines to enter the clinical trial mode. The jab of this vaccine has received worldwide approval in December 2020 and holds an efficacy rate of over 80 per cent. It stands at par with other approved vaccines and is being utilized in many countries, as it is economical too.

However recently, Oxford-AstraZeneca is found amidst controversy after its vaccine model, AZD1222 was suspended in Denmark when some of the citizens were subjected to strange side effects including some blood clots.

Following this several other countries too followed the pattern and started suspending this vaccine due to resultant side effects. Hindustan Times reported, “The Netherlands, Denmark, Norway, Ireland, and Iceland temporarily suspended the use of the vaccine after reports of cases of blood clots. Italy and Romania have banned the use of a similar batch of the vaccine. Austria has also stopped the usage of certain batches of the vaccine and Estonia, Lithuania, Latvia, and Luxembourg have suspended the same batch which was suspended by Austria.”

Countries like France and Germany, however, decided to not put a hold on the use of Oxford-AstraZeneca.  The UK's Medicines and Healthcare said,  “Blood clots can occur naturally and are not uncommon. More than 11 million doses of the Covid-19 AstraZeneca vaccine have now been administered across the UK.”

In India too, the vaccine continues to be one of the chief ones being inoculated to the public and is sold under the brand name Covishield.

What has led to the suspension of the Oxford-AstraZeneca vaccine?

Reports say that the Astrazeneca vaccine, AZD1222, resulted in at least 3 healthcare workers in Denmark forming dangerous blood clots and loss of blood platelets.

Times on India reported, “ There have also been around 22 reports of pulmonary embolism and deep vein thrombosis (DVT) found across the UK and Europe, which were the first to approve the vaccine for widescale inoculation, and have signed up to get millions of shots in the coming weeks.”

“The vaccine also grabbed headlines after several unions, including the French authorities, advised healthcare officials to not dose senior citizens with the jab, citing safety concerns,” it added.

It is important to note that the suspension of this vaccine across a few countries is undertaken as a precautionary measure and there has been no official proof that these side effects are a result of the vaccine jab. The British-Swedish pharmaceuticals company AstraZeneca too issued a statement on Monday stating that the vaccine is completely safe for inoculation.

“A careful review of all available safety data of more than 17 million people vaccinated in the European Union (EU) and the UK with Covid-19 vaccine of AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia, in any defined age group, gender, batch or in any particular country,” the company said in a statement.

Furthermore, both World Health Organization and European Medicines Agency, however, have vouched for the credibility of the vaccine

WHO spokeswoman Margaret Harris said, "Yes, we should continue using the AstraZeneca vaccine." "There is no indication to not use it", she added.

The European Medicines Agency also remarked that after evaluations the benefits of the vaccine overpower and outweigh the risks. Thus, the agency indicated that this vaccine should be continued to be administered.

What are the previously known side-effects of Oxford-AstraZeneca?

The vaccine might result in minor reactogenic side-effects, which are temporary. Under the Covishield (Indian version of the vaccine) guidelines it is stated that the possible list of side-effects includes pain, warmth, itching, bruising, fatigue, chills, fever, nausea, muscle ache, lumps, and malaise. Rare side effects from this vaccine include coughing, breathing difficulties, nervous problems, anaphylaxis.

What is India doing right now?

After a series of suspensions of the AstraZeneca vaccine, the Indian version of it aka Covishiled was subjected to deeper review by the centre to review its side effects and implications after inoculation.

N.K. Arora, a member of India's national task force on Covid-19, said, "We are looking at all the adverse events, particularly serious adverse events like deaths and hospitalization. We will come back if we find anything of concern. "

He further stated that there is "no immediate issue of concern as the number of adverse events (in India) is very, very low." "We are relooking to see if there was an issue of blood clotting", he also added.


   

       if(window.strchfSettings === undefined) window.strchfSettings = {};
   window.strchfSettings.stats = {url: "https://bingedaily-1.storychief.io/en/explained-why-is-oxford-astrazeneca-been-suspended-in-some-countries?id=1815705544&type=26",title: "Explained: Why Is Oxford-AstraZeneca Been Suspended In Some Countries? ",id: "b7e0e674-f104-4b53-ba94-c127ca7805a9"};
           (function(d, s, id) {
     var js, sjs = d.getElementsByTagName(s)[0];
     if (d.getElementById(id)) {window.strchf.update(); return;}
     js = d.createElement(s); js.id = id;
     js.src = "https://d37oebn0w9ir6a.cloudfront.net/scripts/v0/strchf.js";
     js.async = true;
     sjs.parentNode.insertBefore(js, sjs);
   }(document, 'script', 'storychief-jssdk'))
   

Trends

Explained: Why Is Oxford-AstraZeneca Been Suspended In Some Countries?

Oxford-AstraZeneca is found amidst controversy after its vaccine model was suspended in Denmark when some of the citizens were subjected to blood clots.

Amongst all the COVID-19 vaccines, Oxford-Astrazeneca was one of the first vaccines to enter the clinical trial mode. The jab of this vaccine has received worldwide approval in December 2020 and holds an efficacy rate of over 80 per cent. It stands at par with other approved vaccines and is being utilized in many countries, as it is economical too.

However recently, Oxford-AstraZeneca is found amidst controversy after its vaccine model, AZD1222 was suspended in Denmark when some of the citizens were subjected to strange side effects including some blood clots.

Following this several other countries too followed the pattern and started suspending this vaccine due to resultant side effects. Hindustan Times reported, “The Netherlands, Denmark, Norway, Ireland, and Iceland temporarily suspended the use of the vaccine after reports of cases of blood clots. Italy and Romania have banned the use of a similar batch of the vaccine. Austria has also stopped the usage of certain batches of the vaccine and Estonia, Lithuania, Latvia, and Luxembourg have suspended the same batch which was suspended by Austria.”

Countries like France and Germany, however, decided to not put a hold on the use of Oxford-AstraZeneca.  The UK's Medicines and Healthcare said,  “Blood clots can occur naturally and are not uncommon. More than 11 million doses of the Covid-19 AstraZeneca vaccine have now been administered across the UK.”

In India too, the vaccine continues to be one of the chief ones being inoculated to the public and is sold under the brand name Covishield.

What has led to the suspension of the Oxford-AstraZeneca vaccine?

Reports say that the Astrazeneca vaccine, AZD1222, resulted in at least 3 healthcare workers in Denmark forming dangerous blood clots and loss of blood platelets.

Times on India reported, “ There have also been around 22 reports of pulmonary embolism and deep vein thrombosis (DVT) found across the UK and Europe, which were the first to approve the vaccine for widescale inoculation, and have signed up to get millions of shots in the coming weeks.”

“The vaccine also grabbed headlines after several unions, including the French authorities, advised healthcare officials to not dose senior citizens with the jab, citing safety concerns,” it added.

It is important to note that the suspension of this vaccine across a few countries is undertaken as a precautionary measure and there has been no official proof that these side effects are a result of the vaccine jab. The British-Swedish pharmaceuticals company AstraZeneca too issued a statement on Monday stating that the vaccine is completely safe for inoculation.

“A careful review of all available safety data of more than 17 million people vaccinated in the European Union (EU) and the UK with Covid-19 vaccine of AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia, in any defined age group, gender, batch or in any particular country,” the company said in a statement.

Furthermore, both World Health Organization and European Medicines Agency, however, have vouched for the credibility of the vaccine

WHO spokeswoman Margaret Harris said, "Yes, we should continue using the AstraZeneca vaccine." "There is no indication to not use it", she added.

The European Medicines Agency also remarked that after evaluations the benefits of the vaccine overpower and outweigh the risks. Thus, the agency indicated that this vaccine should be continued to be administered.

What are the previously known side-effects of Oxford-AstraZeneca?

The vaccine might result in minor reactogenic side-effects, which are temporary. Under the Covishield (Indian version of the vaccine) guidelines it is stated that the possible list of side-effects includes pain, warmth, itching, bruising, fatigue, chills, fever, nausea, muscle ache, lumps, and malaise. Rare side effects from this vaccine include coughing, breathing difficulties, nervous problems, anaphylaxis.

What is India doing right now?

After a series of suspensions of the AstraZeneca vaccine, the Indian version of it aka Covishiled was subjected to deeper review by the centre to review its side effects and implications after inoculation.

N.K. Arora, a member of India's national task force on Covid-19, said, "We are looking at all the adverse events, particularly serious adverse events like deaths and hospitalization. We will come back if we find anything of concern. "

He further stated that there is "no immediate issue of concern as the number of adverse events (in India) is very, very low." "We are relooking to see if there was an issue of blood clotting", he also added.


   

       if(window.strchfSettings === undefined) window.strchfSettings = {};
   window.strchfSettings.stats = {url: "https://bingedaily-1.storychief.io/en/explained-why-is-oxford-astrazeneca-been-suspended-in-some-countries?id=1815705544&type=26",title: "Explained: Why Is Oxford-AstraZeneca Been Suspended In Some Countries? ",id: "b7e0e674-f104-4b53-ba94-c127ca7805a9"};
           (function(d, s, id) {
     var js, sjs = d.getElementsByTagName(s)[0];
     if (d.getElementById(id)) {window.strchf.update(); return;}
     js = d.createElement(s); js.id = id;
     js.src = "https://d37oebn0w9ir6a.cloudfront.net/scripts/v0/strchf.js";
     js.async = true;
     sjs.parentNode.insertBefore(js, sjs);
   }(document, 'script', 'storychief-jssdk'))
   

Trends

Explained: Why Is Oxford-AstraZeneca Been Suspended In Some Countries?

Oxford-AstraZeneca is found amidst controversy after its vaccine model was suspended in Denmark when some of the citizens were subjected to blood clots.

Amongst all the COVID-19 vaccines, Oxford-Astrazeneca was one of the first vaccines to enter the clinical trial mode. The jab of this vaccine has received worldwide approval in December 2020 and holds an efficacy rate of over 80 per cent. It stands at par with other approved vaccines and is being utilized in many countries, as it is economical too.

However recently, Oxford-AstraZeneca is found amidst controversy after its vaccine model, AZD1222 was suspended in Denmark when some of the citizens were subjected to strange side effects including some blood clots.

Following this several other countries too followed the pattern and started suspending this vaccine due to resultant side effects. Hindustan Times reported, “The Netherlands, Denmark, Norway, Ireland, and Iceland temporarily suspended the use of the vaccine after reports of cases of blood clots. Italy and Romania have banned the use of a similar batch of the vaccine. Austria has also stopped the usage of certain batches of the vaccine and Estonia, Lithuania, Latvia, and Luxembourg have suspended the same batch which was suspended by Austria.”

Countries like France and Germany, however, decided to not put a hold on the use of Oxford-AstraZeneca.  The UK's Medicines and Healthcare said,  “Blood clots can occur naturally and are not uncommon. More than 11 million doses of the Covid-19 AstraZeneca vaccine have now been administered across the UK.”

In India too, the vaccine continues to be one of the chief ones being inoculated to the public and is sold under the brand name Covishield.

What has led to the suspension of the Oxford-AstraZeneca vaccine?

Reports say that the Astrazeneca vaccine, AZD1222, resulted in at least 3 healthcare workers in Denmark forming dangerous blood clots and loss of blood platelets.

Times on India reported, “ There have also been around 22 reports of pulmonary embolism and deep vein thrombosis (DVT) found across the UK and Europe, which were the first to approve the vaccine for widescale inoculation, and have signed up to get millions of shots in the coming weeks.”

“The vaccine also grabbed headlines after several unions, including the French authorities, advised healthcare officials to not dose senior citizens with the jab, citing safety concerns,” it added.

It is important to note that the suspension of this vaccine across a few countries is undertaken as a precautionary measure and there has been no official proof that these side effects are a result of the vaccine jab. The British-Swedish pharmaceuticals company AstraZeneca too issued a statement on Monday stating that the vaccine is completely safe for inoculation.

“A careful review of all available safety data of more than 17 million people vaccinated in the European Union (EU) and the UK with Covid-19 vaccine of AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia, in any defined age group, gender, batch or in any particular country,” the company said in a statement.

Furthermore, both World Health Organization and European Medicines Agency, however, have vouched for the credibility of the vaccine

WHO spokeswoman Margaret Harris said, "Yes, we should continue using the AstraZeneca vaccine." "There is no indication to not use it", she added.

The European Medicines Agency also remarked that after evaluations the benefits of the vaccine overpower and outweigh the risks. Thus, the agency indicated that this vaccine should be continued to be administered.

What are the previously known side-effects of Oxford-AstraZeneca?

The vaccine might result in minor reactogenic side-effects, which are temporary. Under the Covishield (Indian version of the vaccine) guidelines it is stated that the possible list of side-effects includes pain, warmth, itching, bruising, fatigue, chills, fever, nausea, muscle ache, lumps, and malaise. Rare side effects from this vaccine include coughing, breathing difficulties, nervous problems, anaphylaxis.

What is India doing right now?

After a series of suspensions of the AstraZeneca vaccine, the Indian version of it aka Covishiled was subjected to deeper review by the centre to review its side effects and implications after inoculation.

N.K. Arora, a member of India's national task force on Covid-19, said, "We are looking at all the adverse events, particularly serious adverse events like deaths and hospitalization. We will come back if we find anything of concern. "

He further stated that there is "no immediate issue of concern as the number of adverse events (in India) is very, very low." "We are relooking to see if there was an issue of blood clotting", he also added.


   

       if(window.strchfSettings === undefined) window.strchfSettings = {};
   window.strchfSettings.stats = {url: "https://bingedaily-1.storychief.io/en/explained-why-is-oxford-astrazeneca-been-suspended-in-some-countries?id=1815705544&type=26",title: "Explained: Why Is Oxford-AstraZeneca Been Suspended In Some Countries? ",id: "b7e0e674-f104-4b53-ba94-c127ca7805a9"};
           (function(d, s, id) {
     var js, sjs = d.getElementsByTagName(s)[0];
     if (d.getElementById(id)) {window.strchf.update(); return;}
     js = d.createElement(s); js.id = id;
     js.src = "https://d37oebn0w9ir6a.cloudfront.net/scripts/v0/strchf.js";
     js.async = true;
     sjs.parentNode.insertBefore(js, sjs);
   }(document, 'script', 'storychief-jssdk'))
   

WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO